Safran’s FY 20 result beat estimates. However, the guidance is a clear miss compared to both our estimates and the consensus. The good momentum seen in Q4 20 is currently wiped out by the spread of variants of Coronavirus as well as the easing pace of recovery in China.
25 Feb 2021
FY20 met all expectations, but the recovery is not yet on
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY20 met all expectations, but the recovery is not yet on
- Published:
25 Feb 2021 -
Author:
Hugo Paternoster -
Pages:
2
Safran’s FY 20 result beat estimates. However, the guidance is a clear miss compared to both our estimates and the consensus. The good momentum seen in Q4 20 is currently wiped out by the spread of variants of Coronavirus as well as the easing pace of recovery in China.